Synlogic mergers with Mirna Therapeutics
Synlogic Inc said May 16 that it has agreed to merge with a subsidiary of Mirna Therapeutics Inc. Synlogic also recently closed a $42 million Series C preferred stock financing from investors including Aju IB Investment, Ally Bridge Group, Arctic Aurora LifeScience, CLI Ventures, Perceptive Advisors, Rock Springs Capital, and others. Existing investors, Atlas Venture, Deerfield, New Enterprise Associates, and OrbiMed also participated. Synlogic, of Cambridge, Massachusetts, is developing a class of living medicines.
16 May 2017•9 mins read
